Zhu and his research team first analyzed the F proteins used in development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine that has ...
Zhu and his research team first analyzed the F proteins used in development of four existing RSV vaccines—the commercially available Arexvy, mResvia and Abrysvo, and an experimental vaccine that ...
a vaccine for respiratory syncytial virus that competes with GSK’s Arexvy. GSK alleges that Abrysvo or its “biological active substances” infringe US Patent No. 12,139,512, which was issued Nov. 12 ...
The bottom half of the list featured Reckitt Benckiser’s Mucinex, AstraZeneca’s Breztri Aerosphere, Otsuka’s Rexulti, Haleon’s Robitussin and GSK’s RSV vaccine Arexvy. Robitussin had the lowest ...
According to the analyst, while forecasts for long-acting HIV injectables, Ojjaara in myelofibrosis, and future pipeline projects remain optimistic, potential headwinds for Arexvy & Shingrix, as well ...
TipRanks on MSN22d
GSK downgraded to Hold from Buy at JefferiesWhile GSK’s fundamental value remains compelling, overhangs for the company’s Arexvy and Shingrix vaccines, “more subdued” ...
According to the analyst, while forecasts for long-acting HIV injectables, Ojjaara in myelofibrosis, and future pipeline projects remain optimistic, potential headwinds for Arexvy & Shingrix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback